Titus Brinker received two prizes for developing innovative software that uses artificial intelligence (AI) to help dermatologists screen for skin cancer in the future. As the winner of the "Vision Zero" Innovation Award and the "AI Champions Baden-Württemberg 2023", the dermatologist and head of the Digital Biomarkers for Oncology junior research group at the German Cancer Research Center (DKFZ) proves how the use of AI can improve skin cancer screening. The Vision Zero Innovation Award also highlighted Titus Brinker's achievements in the field of digital cancer prevention and diagnostics since 2011.
Titus Brinker's latest project has developed an AI assistance system that can diagnose black skin cancer, which is often difficult to distinguish from benign moles, more accurately on the digital image than experienced dermatologists. For this project, he worked together with his DKFZ team and 116 dermatologists worldwide. For the first time, the AI can explain and justify its diagnosis by naming and describing the relevant structural features of the skin change in technical language and drawing them precisely into the image recordings. That way, physicians can easily understand, interpret, and verify the digital diagnosis for the patient. This integration of AI into dermatologists' treatment can ensure better and safer patient screening.
Currently, the team is working with industrial companies to incorporate the new software into dermatoscopes and, thus, better integrate their technology into everyday medical practice in the future.
For more information on the Digital Biomarkers for Oncology Junior Research Group, follow this link.
For information about the winners of the "KI-Champions Baden-Württemberg 2023," follow this link.
Photo: Michael M. Roth, MicialMedia